Community Socioeconomic Deprivation Predicts Nonalcoholic Steatohepatitis

In order to determine the relationship between socioeconomic deprivation and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH), we retrospectively reviewed the electronic medical records of 1,430 patients in a large tertiary health care network in New York. These patients...

Full description

Saved in:
Bibliographic Details
Published inHepatology communications Vol. 6; no. 3; pp. 550 - 560
Main Authors Giammarino, Alexa M., Qiu, He, Bulsara, Kishen, Khan, Sabrina, Jiang, Yu, Da, Ben L., Bernstein, David E., Satapathy, Sanjaya K.
Format Journal Article
LanguageEnglish
Published United States Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins 01.03.2022
John Wiley and Sons Inc
Wolters Kluwer Health/LWW
Subjects
Online AccessGet full text
ISSN2471-254X
2471-254X
DOI10.1002/hep4.1831

Cover

Abstract In order to determine the relationship between socioeconomic deprivation and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH), we retrospectively reviewed the electronic medical records of 1,430 patients in a large tertiary health care network in New York. These patients underwent liver biopsy over a 10‐year period and were included in our study if they had evidence of NAFLD/NASH on liver biopsy. Zip codes were used to obtain data necessary to derive the social deprivation index (SDI) from the US Bureau of the Census. The high‐SDI group was compared to the low‐SDI group. Univariate and multivariate logistic regressions were performed to assess association between socioeconomic factors and NAFLD parameters, including presence of NASH (NAFLD activity score >4), moderate to severe steatosis (>33%), and significant fibrosis (S2‐S4). We included 614 patients with NAFLD/NASH; the median SDI was 31.5. Hemoglobin A1c values were higher in the high‐SDI group compared to the low‐SDI group (6.46 vs. 6.12, P = 0.02). Socioeconomic factors, such as private versus public health care, percentage being foreign born, percentage without a car, percentage with higher needs (<5 years old and >65 years old), and percentage currently living in renter‐occupied and crowded housing units, showed statistically significant associations in predicting NASH. After adjusting for patient age, sex, race, body mass index, and diabetes, we saw a significant association between four or more socioeconomic parameters in predicting NASH (odds ratio [OR], 1.71; 95% confidence interval [CI], 1.099‐2.856; P = 0.0190) and six or more socioeconomic parameters in predicting severe steatosis (OR, 1.498; 95% CI, 1.031‐2.176; P = 0.0338) but no significant correlation between the number of socioeconomic parameters and significant fibrosis. Conclusion: Greater number of socioeconomic determinants (four or more) are associated with greater severity of NASH. Awareness of NAFLD/NASH needs to be raised in communities with high socioeconomic deprivation.
AbstractList In order to determine the relationship between socioeconomic deprivation and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH), we retrospectively reviewed the electronic medical records of 1,430 patients in a large tertiary health care network in New York. These patients underwent liver biopsy over a 10-year period and were included in our study if they had evidence of NAFLD/NASH on liver biopsy. Zip codes were used to obtain data necessary to derive the social deprivation index (SDI) from the US Bureau of the Census. The high-SDI group was compared to the low-SDI group. Univariate and multivariate logistic regressions were performed to assess association between socioeconomic factors and NAFLD parameters, including presence of NASH (NAFLD activity score >4), moderate to severe steatosis (>33%), and significant fibrosis (S2-S4). We included 614 patients with NAFLD/NASH; the median SDI was 31.5. Hemoglobin A1c values were higher in the high-SDI group compared to the low-SDI group (6.46 vs. 6.12, P = 0.02). Socioeconomic factors, such as private versus public health care, percentage being foreign born, percentage without a car, percentage with higher needs (<5 years old and >65 years old), and percentage currently living in renter-occupied and crowded housing units, showed statistically significant associations in predicting NASH. After adjusting for patient age, sex, race, body mass index, and diabetes, we saw a significant association between four or more socioeconomic parameters in predicting NASH (odds ratio [OR], 1.71; 95% confidence interval [CI], 1.099-2.856; P = 0.0190) and six or more socioeconomic parameters in predicting severe steatosis (OR, 1.498; 95% CI, 1.031-2.176; P = 0.0338) but no significant correlation between the number of socioeconomic parameters and significant fibrosis. Conclusion: Greater number of socioeconomic determinants (four or more) are associated with greater severity of NASH. Awareness of NAFLD/NASH needs to be raised in communities with high socioeconomic deprivation.
In order to determine the relationship between socioeconomic deprivation and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH), we retrospectively reviewed the electronic medical records of 1,430 patients in a large tertiary health care network in New York. These patients underwent liver biopsy over a 10-year period and were included in our study if they had evidence of NAFLD/NASH on liver biopsy. Zip codes were used to obtain data necessary to derive the social deprivation index (SDI) from the US Bureau of the Census. The high-SDI group was compared to the low-SDI group. Univariate and multivariate logistic regressions were performed to assess association between socioeconomic factors and NAFLD parameters, including presence of NASH (NAFLD activity score >4), moderate to severe steatosis (>33%), and significant fibrosis (S2-S4). We included 614 patients with NAFLD/NASH; the median SDI was 31.5. Hemoglobin A1c values were higher in the high-SDI group compared to the low-SDI group (6.46 vs. 6.12, P = 0.02). Socioeconomic factors, such as private versus public health care, percentage being foreign born, percentage without a car, percentage with higher needs (<5 years old and >65 years old), and percentage currently living in renter-occupied and crowded housing units, showed statistically significant associations in predicting NASH. After adjusting for patient age, sex, race, body mass index, and diabetes, we saw a significant association between four or more socioeconomic parameters in predicting NASH (odds ratio [OR], 1.71; 95% confidence interval [CI], 1.099-2.856; P = 0.0190) and six or more socioeconomic parameters in predicting severe steatosis (OR, 1.498; 95% CI, 1.031-2.176; P = 0.0338) but no significant correlation between the number of socioeconomic parameters and significant fibrosis. Conclusion: Greater number of socioeconomic determinants (four or more) are associated with greater severity of NASH. Awareness of NAFLD/NASH needs to be raised in communities with high socioeconomic deprivation.In order to determine the relationship between socioeconomic deprivation and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH), we retrospectively reviewed the electronic medical records of 1,430 patients in a large tertiary health care network in New York. These patients underwent liver biopsy over a 10-year period and were included in our study if they had evidence of NAFLD/NASH on liver biopsy. Zip codes were used to obtain data necessary to derive the social deprivation index (SDI) from the US Bureau of the Census. The high-SDI group was compared to the low-SDI group. Univariate and multivariate logistic regressions were performed to assess association between socioeconomic factors and NAFLD parameters, including presence of NASH (NAFLD activity score >4), moderate to severe steatosis (>33%), and significant fibrosis (S2-S4). We included 614 patients with NAFLD/NASH; the median SDI was 31.5. Hemoglobin A1c values were higher in the high-SDI group compared to the low-SDI group (6.46 vs. 6.12, P = 0.02). Socioeconomic factors, such as private versus public health care, percentage being foreign born, percentage without a car, percentage with higher needs (<5 years old and >65 years old), and percentage currently living in renter-occupied and crowded housing units, showed statistically significant associations in predicting NASH. After adjusting for patient age, sex, race, body mass index, and diabetes, we saw a significant association between four or more socioeconomic parameters in predicting NASH (odds ratio [OR], 1.71; 95% confidence interval [CI], 1.099-2.856; P = 0.0190) and six or more socioeconomic parameters in predicting severe steatosis (OR, 1.498; 95% CI, 1.031-2.176; P = 0.0338) but no significant correlation between the number of socioeconomic parameters and significant fibrosis. Conclusion: Greater number of socioeconomic determinants (four or more) are associated with greater severity of NASH. Awareness of NAFLD/NASH needs to be raised in communities with high socioeconomic deprivation.
In order to determine the relationship between socioeconomic deprivation and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH), we retrospectively reviewed the electronic medical records of 1,430 patients in a large tertiary health care network in New York. These patients underwent liver biopsy over a 10‐year period and were included in our study if they had evidence of NAFLD/NASH on liver biopsy. Zip codes were used to obtain data necessary to derive the social deprivation index (SDI) from the US Bureau of the Census. The high‐SDI group was compared to the low‐SDI group. Univariate and multivariate logistic regressions were performed to assess association between socioeconomic factors and NAFLD parameters, including presence of NASH (NAFLD activity score >4), moderate to severe steatosis (>33%), and significant fibrosis (S2‐S4). We included 614 patients with NAFLD/NASH; the median SDI was 31.5. Hemoglobin A1c values were higher in the high‐SDI group compared to the low‐SDI group (6.46 vs. 6.12, P  = 0.02). Socioeconomic factors, such as private versus public health care, percentage being foreign born, percentage without a car, percentage with higher needs (<5 years old and >65 years old), and percentage currently living in renter‐occupied and crowded housing units, showed statistically significant associations in predicting NASH. After adjusting for patient age, sex, race, body mass index, and diabetes, we saw a significant association between four or more socioeconomic parameters in predicting NASH (odds ratio [OR], 1.71; 95% confidence interval [CI], 1.099‐2.856; P  = 0.0190) and six or more socioeconomic parameters in predicting severe steatosis (OR, 1.498; 95% CI, 1.031‐2.176; P  = 0.0338) but no significant correlation between the number of socioeconomic parameters and significant fibrosis. Conclusion: Greater number of socioeconomic determinants (four or more) are associated with greater severity of NASH. Awareness of NAFLD/NASH needs to be raised in communities with high socioeconomic deprivation.
In order to determine the relationship between socioeconomic deprivation and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH), we retrospectively reviewed the electronic medical records of 1,430 patients in a large tertiary health care network in New York. These patients underwent liver biopsy over a 10‐year period and were included in our study if they had evidence of NAFLD/NASH on liver biopsy. Zip codes were used to obtain data necessary to derive the social deprivation index (SDI) from the US Bureau of the Census. The high‐SDI group was compared to the low‐SDI group. Univariate and multivariate logistic regressions were performed to assess association between socioeconomic factors and NAFLD parameters, including presence of NASH (NAFLD activity score >4), moderate to severe steatosis (>33%), and significant fibrosis (S2‐S4). We included 614 patients with NAFLD/NASH; the median SDI was 31.5. Hemoglobin A1c values were higher in the high‐SDI group compared to the low‐SDI group (6.46 vs. 6.12, P = 0.02). Socioeconomic factors, such as private versus public health care, percentage being foreign born, percentage without a car, percentage with higher needs (<5 years old and >65 years old), and percentage currently living in renter‐occupied and crowded housing units, showed statistically significant associations in predicting NASH. After adjusting for patient age, sex, race, body mass index, and diabetes, we saw a significant association between four or more socioeconomic parameters in predicting NASH (odds ratio [OR], 1.71; 95% confidence interval [CI], 1.099‐2.856; P = 0.0190) and six or more socioeconomic parameters in predicting severe steatosis (OR, 1.498; 95% CI, 1.031‐2.176; P = 0.0338) but no significant correlation between the number of socioeconomic parameters and significant fibrosis. Conclusion: Greater number of socioeconomic determinants (four or more) are associated with greater severity of NASH. Awareness of NAFLD/NASH needs to be raised in communities with high socioeconomic deprivation.
Author Khan, Sabrina
Qiu, He
Da, Ben L.
Giammarino, Alexa M.
Bulsara, Kishen
Satapathy, Sanjaya K.
Jiang, Yu
Bernstein, David E.
AuthorAffiliation 1 Donald and Barbara Zucker School of Medicine at Hofstra University Northwell Health Hempstead NY USA
3 Division of Gastroenterology and Hepatology Department of Medicine Rutgers New Jersey Medical School Newark NJ USA
4 School of Public Health University of Memphis Memphis TN USA
2 Division of Hepatology at Sandra Atlas Bass Center for Liver Diseases and Transplantation Northshore University Hospital Manhasset NY USA
AuthorAffiliation_xml – name: 3 Division of Gastroenterology and Hepatology Department of Medicine Rutgers New Jersey Medical School Newark NJ USA
– name: 1 Donald and Barbara Zucker School of Medicine at Hofstra University Northwell Health Hempstead NY USA
– name: 2 Division of Hepatology at Sandra Atlas Bass Center for Liver Diseases and Transplantation Northshore University Hospital Manhasset NY USA
– name: 4 School of Public Health University of Memphis Memphis TN USA
Author_xml – sequence: 1
  givenname: Alexa M.
  surname: Giammarino
  fullname: Giammarino, Alexa M.
  organization: Northshore University Hospital
– sequence: 2
  givenname: He
  surname: Qiu
  fullname: Qiu, He
  organization: Rutgers New Jersey Medical School
– sequence: 3
  givenname: Kishen
  surname: Bulsara
  fullname: Bulsara, Kishen
  organization: Northwell Health
– sequence: 4
  givenname: Sabrina
  surname: Khan
  fullname: Khan, Sabrina
  organization: Northwell Health
– sequence: 5
  givenname: Yu
  surname: Jiang
  fullname: Jiang, Yu
  organization: University of Memphis
– sequence: 6
  givenname: Ben L.
  orcidid: 0000-0002-7750-240X
  surname: Da
  fullname: Da, Ben L.
  organization: Northshore University Hospital
– sequence: 7
  givenname: David E.
  surname: Bernstein
  fullname: Bernstein, David E.
  organization: Northshore University Hospital
– sequence: 8
  givenname: Sanjaya K.
  orcidid: 0000-0003-0153-2829
  surname: Satapathy
  fullname: Satapathy, Sanjaya K.
  email: ssatapat@northwell.edu
  organization: Northshore University Hospital
BackLink https://www.ncbi.nlm.nih.gov/pubmed/34668658$$D View this record in MEDLINE/PubMed
BookMark eNp1kk1vEzEQhi1URD_ogT-AInGBQ1p_rr0XJBQKjVRBpYLEzXKc2cbR7k6wvUX593U-itoKTh7bz7zzamaOyUGPPRDyhtEzRik_X8BKnjEj2AtyxKVmY67kr4NH8SE5TWlJKWU1Z6ymr8ihkFVlKmWOyHSCXTf0Ia9HN-gDgsceu-BHn2EVw53LAfvRdYR58DmNvmHvWo8LbAtxk8FlLOULlEN6TV42rk1wuj9PyM8vFz8ml-Or71-nk09XY6-2jpxSXjEO1DPeAKfM1U4KmJVT63IVghpnoGa8nmum-Vw3Qou65rrSsxKfkOlOd45uaYvJzsW1RRfs9gHjrXUxB9-CdWB4yXBczYRsfF070UiqKk-ZkdSZovVxp7UaZh3MPfQ5uvaJ6NOfPizsLd5ZY3Tppy4C7_cCEX8PkLLtQvLQtq4HHJLlqhRiWmlV0HfP0CUOsfSzUJXgXEojNo7ePnb018rDxApwvgN8xJQiNNaHvB1TMRhay6jdrIXdrIXdrEXJ-PAs40H0X-xe_U9oYf1_0F5eXMttxj05vMWK
CitedBy_id crossref_primary_10_20517_mtod_2023_45
crossref_primary_10_3390_jcm14061950
crossref_primary_10_1007_s10620_024_08722_0
crossref_primary_10_1177_20406223241264539
crossref_primary_10_1111_jvh_14006
crossref_primary_10_1097_IN9_0000000000000037
crossref_primary_10_1097_HC9_0000000000000324
crossref_primary_10_1016_j_cgh_2024_10_019
crossref_primary_10_1371_journal_pone_0301774
crossref_primary_10_34172_aim_30020
crossref_primary_10_1371_journal_pone_0306825
crossref_primary_10_1097_HEP_0000000000001058
crossref_primary_10_1186_s12916_024_03315_0
crossref_primary_10_14309_ctg_0000000000000495
crossref_primary_10_1016_j_jceh_2024_101359
crossref_primary_10_1136_jech_2022_220234
crossref_primary_10_14309_ajg_0000000000002905
crossref_primary_10_1111_apt_17652
crossref_primary_10_3390_healthcare12080816
crossref_primary_10_1159_000539371
crossref_primary_10_1186_s13293_022_00475_7
crossref_primary_10_1210_jendso_bvae176
crossref_primary_10_2337_dsi23_0010
crossref_primary_10_1016_j_jhep_2023_01_026
crossref_primary_10_1016_j_jhep_2024_04_031
crossref_primary_10_1002_jpn3_12399
crossref_primary_10_1038_s41575_023_00800_4
crossref_primary_10_1038_s41575_024_00959_4
crossref_primary_10_1097_LVT_0000000000000421
crossref_primary_10_1016_j_ajt_2024_02_009
Cites_doi 10.1002/hep.30251
10.4254/wjh.v10.i8.530
10.1002/hep.31173
10.1093/jn/nxz212
10.21037/tgh.2019.09.08
10.1002/hep4.1599
10.1002/med.21515
10.4103/2230-8210.163172
10.1016/j.socscimed.2013.11.033
10.1097/PSY.0b013e3181c484dc
10.3748/wjg.v22.i36.8226
10.4254/wjh.v8.i33.1459
10.1053/j.gastro.2020.01.052
10.1016/j.cgh.2008.11.005
10.5114/ceh.2019.87635
10.1002/hep4.1534
10.1016/j.jhep.2018.05.036
10.1016/S0022-3999(02)00303-3
10.1016/j.jhep.2004.09.012
10.2337/diacare.24.11.1936
10.3748/wjg.v23.i47.8263
10.7326/0003-4819-143-10-200511150-00009
10.1002/hep4.1419
10.1002/hep.31158
10.1002/hep.28431
10.1002/hep.20701
10.1002/hep.24726
10.1053/j.gastro.2005.04.014
10.1038/s41598-018-33419-6
10.1002/hep.29466
10.1016/S2468-2667(18)30111-7
10.1038/nrgastro.2017.109
10.1002/cld.65
10.1097/MPG.0000000000002527
10.3892/br.2014.309
10.3748/wjg.v11.i24.3808
ContentType Journal Article
Copyright 2021 The Authors. published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.
2021 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.
2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: 2021 The Authors. published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.
– notice: 2021 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.
– notice: 2022. This work is published under http://creativecommons.org/licenses/by-nc-nd/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 24P
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
7X8
5PM
DOA
DOI 10.1002/hep4.1831
DatabaseName Wiley Online Library Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ Directory of Open Access Journals
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE
MEDLINE - Academic
CrossRef

Publicly Available Content Database


Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: 24P
  name: Wiley Online Library Open Access
  url: https://authorservices.wiley.com/open-science/open-access/browse-journals.html
  sourceTypes: Publisher
– sequence: 3
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 4
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 5
  dbid: 7X7
  name: Health & Medical Collection
  url: https://search.proquest.com/healthcomplete
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
DocumentTitleAlternate GIAMMARINO et al
EISSN 2471-254X
EndPage 560
ExternalDocumentID oai_doaj_org_article_ae827f3a25b34fc99a3f4056c01840a8
PMC8870017
34668658
10_1002_hep4_1831
HEP41831
Genre article
Journal Article
GeographicLocations New York
United States--US
GeographicLocations_xml – name: New York
– name: United States--US
GroupedDBID 0R~
1OC
24P
53G
7X7
8FI
8FJ
AAAAV
AAHHS
AAHPQ
AAIQE
AAOCO
ABUWG
ACCFJ
ACCMX
ACILI
ACXJB
ACXQS
ADBBV
ADGGA
ADHPY
ADKYN
ADPDF
ADZMN
ADZOD
AECAP
AEEZP
AEQDE
AFDTB
AFKRA
AFUWQ
AHQNM
AIWBW
AJAOE
AJBDE
AJCLO
AJNWD
AJZMW
AKCTQ
ALIPV
ALKUP
ALMA_UNASSIGNED_HOLDINGS
ALUQN
AMNEI
AOHHW
AOIJS
AVUZU
BCNDV
BENPR
BPHCQ
BVXVI
CCPQU
DIWNM
EBS
EEVPB
EJD
FCALG
FYUFA
GQDEL
GROUPED_DOAJ
HMCUK
HYE
IAO
IHR
IKREB
INH
ITC
M~E
OK1
OVD
OVDNE
PIMPY
PQQKQ
PROAC
RPM
TEORI
TSPGW
UKHRP
WIN
AASCR
AAYXX
ABJNI
ABVCZ
ABZZY
AFBFQ
AINUH
AOQMC
CITATION
GNXGY
HLJTE
PHGZM
PHGZT
CGR
CUY
CVF
ECM
EIF
NPM
3V.
7XB
8FK
AAMMB
AEFGJ
AGXDD
AIDQK
AIDYY
AZQEC
DWQXO
K9.
PKEHL
PQEST
PQUKI
PRINS
7X8
ADKSD
PUEGO
5PM
ID FETCH-LOGICAL-c5471-2a55c512e0c12fe201a9a43eb1a9772013308a8e9129d7172d7f373992767b7f3
IEDL.DBID DOA
ISSN 2471-254X
IngestDate Wed Aug 27 01:05:24 EDT 2025
Thu Aug 21 17:51:31 EDT 2025
Mon Sep 08 11:08:16 EDT 2025
Wed Aug 13 03:55:27 EDT 2025
Thu Apr 03 06:59:52 EDT 2025
Tue Jul 01 02:48:38 EDT 2025
Thu Apr 24 23:02:27 EDT 2025
Wed Jan 22 16:27:02 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Language English
License Attribution-NonCommercial-NoDerivs
2021 The Authors. Hepatology Communications published by Wiley Periodicals LLC on behalf of American Association for the Study of Liver Diseases.
This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c5471-2a55c512e0c12fe201a9a43eb1a9772013308a8e9129d7172d7f373992767b7f3
Notes Potential conflict of interest: Dr. Bernstein advises Novartis. The other authors have nothing to report.
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-7750-240X
0000-0003-0153-2829
0000-0002-7750-240
OpenAccessLink https://doaj.org/article/ae827f3a25b34fc99a3f4056c01840a8
PMID 34668658
PQID 2632244838
PQPubID 4370311
PageCount 11
ParticipantIDs doaj_primary_oai_doaj_org_article_ae827f3a25b34fc99a3f4056c01840a8
pubmedcentral_primary_oai_pubmedcentral_nih_gov_8870017
proquest_miscellaneous_2584017575
proquest_journals_2632244838
pubmed_primary_34668658
crossref_citationtrail_10_1002_hep4_1831
crossref_primary_10_1002_hep4_1831
wiley_primary_10_1002_hep4_1831_HEP41831
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate March 2022
PublicationDateYYYYMMDD 2022-03-01
PublicationDate_xml – month: 03
  year: 2022
  text: March 2022
PublicationDecade 2020
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: New York
– name: Hoboken
PublicationTitle Hepatology communications
PublicationTitleAlternate Hepatol Commun
PublicationYear 2022
Publisher Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
John Wiley and Sons Inc
Wolters Kluwer Health/LWW
Publisher_xml – name: Wolters Kluwer Health Medical Research, Lippincott Williams & Wilkins
– name: John Wiley and Sons Inc
– name: Wolters Kluwer Health/LWW
References 2019; 3
2015; 19
2019; 5
2002; 53
2017; 23
2019; 39
2005; 41
2005; 42
2020; 10
2018; 67
2001; 24
2016; 15
2012; 55
2018; 69
2016; 4
2020; 5
2018; 8
2020; 4
2018; 3
2012; 1
2014; 2
2005; 143
2020; 72
2017; 11
2020; 70
2019; 69
2020; 150
2005; 129
2016; 64
2009; 7
2020; 158
2018; 10
2016; 8
2005; 11
2018; 15
2010; 72
2014; 102
2016; 22
(hep41831-bib-0040-20241115) 2012; 55
(hep41831-bib-0038-20241115) 2020; 70
(hep41831-bib-0003-20241115) 2016; 64
(hep41831-bib-0037-20241115) 2014; 2
(hep41831-bib-0017-20241115) 2016; 8
(hep41831-bib-0021-20241115) 2010; 72
(hep41831-bib-0023-20241115) 2002; 53
(hep41831-bib-0024-20241115) 2018; 3
(hep41831-bib-0041-20241115) 2005; 41
(hep41831-bib-0013-20241115) 2018; 15
(hep41831-bib-0032-20241115) 2020; 4
(hep41831-bib-0008-20241115) 2019; 69
(hep41831-bib-0009-20241115) 2020; 4
(hep41831-bib-0002-20241115) 2018; 67
(hep41831-bib-0016-20241115) 2020; 150
(hep41831-bib-0004-20241115) 2018; 69
(hep41831-bib-0022-20241115) 2017; 11
(hep41831-bib-0036-20241115) 2015; 19
(hep41831-bib-0043-20241115) 2018; 10
(hep41831-bib-0011-20241115) 2020; 10
(hep41831-bib-0015-20241115) 2020; 72
(hep41831-bib-0006-20241115) 2009; 7
(hep41831-bib-0012-20241115) 2017; 23
(hep41831-bib-0035-20241115) 2012; 1
(hep41831-bib-0029-20241115) 2020; 5
(hep41831-bib-0044-20241115) 2016; 22
(hep41831-bib-0007-20241115) 2019; 3
(hep41831-bib-0030-20241115) 2018; 8
(hep41831-bib-0018-20241115) 2005; 143
(hep41831-bib-0031-20241115) 2005; 42
(hep41831-bib-0034-20241115) 2014; 102
(hep41831-bib-0033-20241115) 2016; 4
(hep41831-bib-0019-20241115) 2005; 129
(hep41831-bib-0005-20241115) 2020; 72
(hep41831-bib-0014-20241115) 2016; 15
(hep41831-bib-0020-20241115) 2001; 24
(hep41831-bib-0039-20241115) 2005; 11
(hep41831-bib-0001-20241115) 2020; 158
(hep41831-bib-0028-20241115) 2019; 39
(hep41831-bib-0042-20241115) 2019; 5
References_xml – volume: 22
  start-page: 8226
  year: 2016
  end-page: 8233
  article-title: Clinical guidelines of non‐alcoholic fatty liver disease: a systematic review
  publication-title: World J Gastroenterol
– volume: 24
  start-page: 1936
  year: 2001
  end-page: 1940
  article-title: Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S
  publication-title: Diabetes Care
– volume: 1
  start-page: 104
  year: 2012
  end-page: 107
  article-title: Nonalcoholic fatty liver disease: indications for liver biopsy and noninvasive biomarkers
  publication-title: Clin Liver Dis (Hoboken)
– volume: 150
  start-page: 91
  year: 2020
  end-page: 98
  article-title: Food insecurity may be an independent risk factor associated with nonalcoholic fatty liver disease among low‐income adults in the United States
  publication-title: J Nutr
– volume: 8
  start-page: 15273
  year: 2018
  article-title: Association between body mass index and fatty liver risk: a dose‐response analysis
  publication-title: Sci Rep
– volume: 41
  start-page: 1313
  year: 2005
  end-page: 1321
  article-title: Design and validation of a histological scoring system for nonalcoholic fatty liver disease
  publication-title: Hepatology
– volume: 4
  year: 2016
  article-title: Socioeconomic status and glycemic control in adult patients with type 2 diabetes: a mediation analysis
  publication-title: BMJ Open Diabetes Res Care
– volume: 3
  start-page: 1459
  year: 2019
  end-page: 1471
  article-title: Mortality related to nonalcoholic fatty liver disease is increasing in the United States
  publication-title: Hepatol Commun
– volume: 11
  start-page: LC18
  year: 2017
  end-page: LC22
  article-title: Association between socioeconomic status and diabetes mellitus: the national socioeconomics survey, 2010 and 2012
  publication-title: J Clin Diagn Res
– volume: 5
  start-page: 16
  year: 2020
  article-title: Epidemiology of non‐alcoholic and alcoholic fatty liver diseases
  publication-title: Transl Gastroenterol Hepatol
– volume: 143
  start-page: 722
  year: 2005
  end-page: 728
  article-title: The metabolic syndrome as a predictor of nonalcoholic fatty liver disease
  publication-title: Ann Intern Med
– volume: 3
  start-page: e365
  year: 2018
  end-page: e373
  article-title: Neighbourhood socioeconomic disadvantage, risk factors, and diabetes from childhood to middle age in the Young Finns Study: a cohort study
  publication-title: Lancet Public Health
– volume: 15
  start-page: 662
  year: 2016
  end-page: 672
  article-title: Economic growth leads to increase of obesity and associated hepatocellular carcinoma in developing countries
  publication-title: Ann Hepatol
– volume: 10
  year: 2020
  article-title: Prevalence trends in non‐alcoholic fatty liver disease at the global, regional and national levels, 1990‐2017: a population‐based observational study
  publication-title: BMJ Open
– volume: 158
  start-page: 1851
  year: 2020
  end-page: 1864
  article-title: Nonalcoholic fatty liver disease 2020: the state of the disease
  publication-title: Gastroenterology
– volume: 5
  start-page: 224
  year: 2019
  end-page: 231
  article-title: Prevalence and risk factors of non‐alcoholic fatty liver disease in southwest Iran: a population‐based case‐control study
  publication-title: Clin Exp Hepatol
– volume: 19
  start-page: 597
  year: 2015
  end-page: 601
  article-title: Profile of liver enzymes in non‐alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes
  publication-title: Indian J Endocrinol Metab
– volume: 4
  start-page: 1769
  year: 2020
  end-page: 1780
  article-title: The growing burden of disability related to nonalcoholic fatty liver disease: data from the global burden of disease 2007‐2017
  publication-title: Hepatol Commun
– volume: 72
  start-page: 1556
  year: 2020
  end-page: 1568
  article-title: Inadequate physical activity and sedentary behavior are independent predictors of nonalcoholic fatty liver disease
  publication-title: Hepatology
– volume: 42
  start-page: 132
  year: 2005
  end-page: 138
  article-title: The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies
  publication-title: J Hepatol
– volume: 11
  start-page: 3808
  year: 2005
  end-page: 3809
  article-title: Nonalcoholic fatty liver disease in developing countries
  publication-title: World J Gastroenterol
– volume: 67
  start-page: 123
  year: 2018
  end-page: 133
  article-title: Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
  publication-title: Hepatology
– volume: 23
  start-page: 8263
  year: 2017
  end-page: 8276
  article-title: Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
  publication-title: World J Gastroenterol
– volume: 70
  start-page: 364
  year: 2020
  end-page: 370
  article-title: Community socioeconomic deprivation and nonalcoholic fatty liver disease severity
  publication-title: J Pediatr Gastroenterol Nutr
– volume: 69
  start-page: 2672
  year: 2019
  end-page: 2682
  article-title: Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
  publication-title: Hepatology
– volume: 8
  start-page: 1459
  year: 2016
  end-page: 1465
  article-title: Neglected features of lifestyle: their relevance in non‐alcoholic fatty liver disease
  publication-title: World J Hepatol
– volume: 129
  start-page: 113
  year: 2005
  end-page: 121
  article-title: The natural history of nonalcoholic fatty liver disease: a population‐based cohort study
  publication-title: Gastroenterology
– volume: 102
  start-page: 58
  year: 2014
  end-page: 68
  article-title: Health capabilities and diabetes self‐management: the impact of economic, social and cultural resources
  publication-title: Soc Sci Med
– volume: 2
  start-page: 633
  year: 2014
  end-page: 636
  article-title: Triglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes
  publication-title: Biomed Rep
– volume: 53
  start-page: 891
  year: 2002
  end-page: 895
  article-title: Epidemiologic evidence for the relation between socioeconomic status and depression, obesity, and diabetes
  publication-title: J Psychosom Res
– volume: 4
  start-page: 1136
  year: 2020
  end-page: 1148
  article-title: Mortality of NAFLD according to the body composition and presence of metabolic abnormalities
  publication-title: Hepatol Commun
– volume: 39
  start-page: 328
  year: 2019
  end-page: 348
  article-title: Progress and challenges in the prevention and control of nonalcoholic fatty liver disease
  publication-title: Med Res Rev
– volume: 69
  start-page: 896
  year: 2018
  end-page: 904
  article-title: Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016‐2030
  publication-title: J Hepatol
– volume: 72
  start-page: 35
  year: 2010
  end-page: 45
  article-title: Subjective socioeconomic status and presence of the metabolic syndrome in midlife community volunteers
  publication-title: Psychosom Med
– volume: 64
  start-page: 73
  year: 2016
  end-page: 84
  article-title: Global epidemiology of nonalcoholic fatty liver disease‐meta‐analytic assessment of prevalence, incidence, and outcomes
  publication-title: Hepatology
– volume: 72
  start-page: 1605
  year: 2020
  end-page: 1616
  article-title: Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD
  publication-title: Hepatology
– volume: 7
  start-page: 234
  year: 2009
  end-page: 238
  article-title: Long‐term follow‐up of patients with nonalcoholic fatty liver
  publication-title: Clin Gastroenterol Hepatol
– volume: 15
  start-page: 11
  year: 2018
  end-page: 20
  article-title: Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
  publication-title: Nat Rev Gastroenterol Hepatol
– volume: 55
  start-page: 769
  year: 2012
  end-page: 780
  article-title: Ethnicity and nonalcoholic fatty liver disease
  publication-title: Hepatology
– volume: 10
  start-page: 530
  year: 2018
  end-page: 542
  article-title: Current status of imaging in nonalcoholic fatty liver disease
  publication-title: World J Hepatol
– volume: 69
  start-page: 2672
  year: 2019
  ident: hep41831-bib-0008-20241115
  article-title: Global perspectives on nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
  publication-title: Hepatology
  doi: 10.1002/hep.30251
– volume: 10
  start-page: 530
  year: 2018
  ident: hep41831-bib-0043-20241115
  article-title: Current status of imaging in nonalcoholic fatty liver disease
  publication-title: World J Hepatol
  doi: 10.4254/wjh.v10.i8.530
– volume: 72
  start-page: 1605
  year: 2020
  ident: hep41831-bib-0005-20241115
  article-title: Changes in the global burden of chronic liver diseases from 2012 to 2017: the growing impact of NAFLD
  publication-title: Hepatology
  doi: 10.1002/hep.31173
– volume: 150
  start-page: 91
  year: 2020
  ident: hep41831-bib-0016-20241115
  article-title: Food insecurity may be an independent risk factor associated with nonalcoholic fatty liver disease among low‐income adults in the United States
  publication-title: J Nutr
  doi: 10.1093/jn/nxz212
– volume: 5
  start-page: 16
  year: 2020
  ident: hep41831-bib-0029-20241115
  article-title: Epidemiology of non‐alcoholic and alcoholic fatty liver diseases
  publication-title: Transl Gastroenterol Hepatol
  doi: 10.21037/tgh.2019.09.08
– volume: 4
  start-page: 1769
  year: 2020
  ident: hep41831-bib-0009-20241115
  article-title: The growing burden of disability related to nonalcoholic fatty liver disease: data from the global burden of disease 2007‐2017
  publication-title: Hepatol Commun
  doi: 10.1002/hep4.1599
– volume: 39
  start-page: 328
  year: 2019
  ident: hep41831-bib-0028-20241115
  article-title: Progress and challenges in the prevention and control of nonalcoholic fatty liver disease
  publication-title: Med Res Rev
  doi: 10.1002/med.21515
– volume: 19
  start-page: 597
  year: 2015
  ident: hep41831-bib-0036-20241115
  article-title: Profile of liver enzymes in non‐alcoholic fatty liver disease in patients with impaired glucose tolerance and newly detected untreated type 2 diabetes
  publication-title: Indian J Endocrinol Metab
  doi: 10.4103/2230-8210.163172
– volume: 102
  start-page: 58
  year: 2014
  ident: hep41831-bib-0034-20241115
  article-title: Health capabilities and diabetes self‐management: the impact of economic, social and cultural resources
  publication-title: Soc Sci Med
  doi: 10.1016/j.socscimed.2013.11.033
– volume: 72
  start-page: 35
  year: 2010
  ident: hep41831-bib-0021-20241115
  article-title: Subjective socioeconomic status and presence of the metabolic syndrome in midlife community volunteers
  publication-title: Psychosom Med
  doi: 10.1097/PSY.0b013e3181c484dc
– volume: 22
  start-page: 8226
  year: 2016
  ident: hep41831-bib-0044-20241115
  article-title: Clinical guidelines of non‐alcoholic fatty liver disease: a systematic review
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v22.i36.8226
– volume: 8
  start-page: 1459
  year: 2016
  ident: hep41831-bib-0017-20241115
  article-title: Neglected features of lifestyle: their relevance in non‐alcoholic fatty liver disease
  publication-title: World J Hepatol
  doi: 10.4254/wjh.v8.i33.1459
– volume: 158
  start-page: 1851
  year: 2020
  ident: hep41831-bib-0001-20241115
  article-title: Nonalcoholic fatty liver disease 2020: the state of the disease
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2020.01.052
– volume: 7
  start-page: 234
  year: 2009
  ident: hep41831-bib-0006-20241115
  article-title: Long‐term follow‐up of patients with nonalcoholic fatty liver
  publication-title: Clin Gastroenterol Hepatol
  doi: 10.1016/j.cgh.2008.11.005
– volume: 11
  start-page: LC18
  year: 2017
  ident: hep41831-bib-0022-20241115
  article-title: Association between socioeconomic status and diabetes mellitus: the national socioeconomics survey, 2010 and 2012
  publication-title: J Clin Diagn Res
– volume: 5
  start-page: 224
  year: 2019
  ident: hep41831-bib-0042-20241115
  article-title: Prevalence and risk factors of non‐alcoholic fatty liver disease in southwest Iran: a population‐based case‐control study
  publication-title: Clin Exp Hepatol
  doi: 10.5114/ceh.2019.87635
– volume: 4
  start-page: 1136
  year: 2020
  ident: hep41831-bib-0032-20241115
  article-title: Mortality of NAFLD according to the body composition and presence of metabolic abnormalities
  publication-title: Hepatol Commun
  doi: 10.1002/hep4.1534
– volume: 69
  start-page: 896
  year: 2018
  ident: hep41831-bib-0004-20241115
  article-title: Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016‐2030
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2018.05.036
– volume: 53
  start-page: 891
  year: 2002
  ident: hep41831-bib-0023-20241115
  article-title: Epidemiologic evidence for the relation between socioeconomic status and depression, obesity, and diabetes
  publication-title: J Psychosom Res
  doi: 10.1016/S0022-3999(02)00303-3
– volume: 42
  start-page: 132
  year: 2005
  ident: hep41831-bib-0031-20241115
  article-title: The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies
  publication-title: J Hepatol
  doi: 10.1016/j.jhep.2004.09.012
– volume: 10
  year: 2020
  ident: hep41831-bib-0011-20241115
  article-title: Prevalence trends in non‐alcoholic fatty liver disease at the global, regional and national levels, 1990‐2017: a population‐based observational study
  publication-title: BMJ Open
– volume: 24
  start-page: 1936
  year: 2001
  ident: hep41831-bib-0020-20241115
  article-title: Projection of diabetes burden through 2050: impact of changing demography and disease prevalence in the U.S
  publication-title: Diabetes Care
  doi: 10.2337/diacare.24.11.1936
– volume: 23
  start-page: 8263
  year: 2017
  ident: hep41831-bib-0012-20241115
  article-title: Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v23.i47.8263
– volume: 143
  start-page: 722
  year: 2005
  ident: hep41831-bib-0018-20241115
  article-title: The metabolic syndrome as a predictor of nonalcoholic fatty liver disease
  publication-title: Ann Intern Med
  doi: 10.7326/0003-4819-143-10-200511150-00009
– volume: 3
  start-page: 1459
  year: 2019
  ident: hep41831-bib-0007-20241115
  article-title: Mortality related to nonalcoholic fatty liver disease is increasing in the United States
  publication-title: Hepatol Commun
  doi: 10.1002/hep4.1419
– volume: 72
  start-page: 1556
  year: 2020
  ident: hep41831-bib-0015-20241115
  article-title: Inadequate physical activity and sedentary behavior are independent predictors of nonalcoholic fatty liver disease
  publication-title: Hepatology
  doi: 10.1002/hep.31158
– volume: 64
  start-page: 73
  year: 2016
  ident: hep41831-bib-0003-20241115
  article-title: Global epidemiology of nonalcoholic fatty liver disease‐meta‐analytic assessment of prevalence, incidence, and outcomes
  publication-title: Hepatology
  doi: 10.1002/hep.28431
– volume: 15
  start-page: 662
  year: 2016
  ident: hep41831-bib-0014-20241115
  article-title: Economic growth leads to increase of obesity and associated hepatocellular carcinoma in developing countries
  publication-title: Ann Hepatol
– volume: 41
  start-page: 1313
  year: 2005
  ident: hep41831-bib-0041-20241115
  article-title: Design and validation of a histological scoring system for nonalcoholic fatty liver disease
  publication-title: Hepatology
  doi: 10.1002/hep.20701
– volume: 4
  year: 2016
  ident: hep41831-bib-0033-20241115
  article-title: Socioeconomic status and glycemic control in adult patients with type 2 diabetes: a mediation analysis
  publication-title: BMJ Open Diabetes Res Care
– volume: 55
  start-page: 769
  year: 2012
  ident: hep41831-bib-0040-20241115
  article-title: Ethnicity and nonalcoholic fatty liver disease
  publication-title: Hepatology
  doi: 10.1002/hep.24726
– volume: 129
  start-page: 113
  year: 2005
  ident: hep41831-bib-0019-20241115
  article-title: The natural history of nonalcoholic fatty liver disease: a population‐based cohort study
  publication-title: Gastroenterology
  doi: 10.1053/j.gastro.2005.04.014
– volume: 8
  start-page: 15273
  year: 2018
  ident: hep41831-bib-0030-20241115
  article-title: Association between body mass index and fatty liver risk: a dose‐response analysis
  publication-title: Sci Rep
  doi: 10.1038/s41598-018-33419-6
– volume: 67
  start-page: 123
  year: 2018
  ident: hep41831-bib-0002-20241115
  article-title: Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease
  publication-title: Hepatology
  doi: 10.1002/hep.29466
– volume: 3
  start-page: e365
  year: 2018
  ident: hep41831-bib-0024-20241115
  article-title: Neighbourhood socioeconomic disadvantage, risk factors, and diabetes from childhood to middle age in the Young Finns Study: a cohort study
  publication-title: Lancet Public Health
  doi: 10.1016/S2468-2667(18)30111-7
– volume: 15
  start-page: 11
  year: 2018
  ident: hep41831-bib-0013-20241115
  article-title: Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
  publication-title: Nat Rev Gastroenterol Hepatol
  doi: 10.1038/nrgastro.2017.109
– volume: 1
  start-page: 104
  year: 2012
  ident: hep41831-bib-0035-20241115
  article-title: Nonalcoholic fatty liver disease: indications for liver biopsy and noninvasive biomarkers
  publication-title: Clin Liver Dis (Hoboken)
  doi: 10.1002/cld.65
– volume: 70
  start-page: 364
  year: 2020
  ident: hep41831-bib-0038-20241115
  article-title: Community socioeconomic deprivation and nonalcoholic fatty liver disease severity
  publication-title: J Pediatr Gastroenterol Nutr
  doi: 10.1097/MPG.0000000000002527
– volume: 2
  start-page: 633
  year: 2014
  ident: hep41831-bib-0037-20241115
  article-title: Triglyceride is strongly associated with nonalcoholic fatty liver disease among markers of hyperlipidemia and diabetes
  publication-title: Biomed Rep
  doi: 10.3892/br.2014.309
– volume: 11
  start-page: 3808
  year: 2005
  ident: hep41831-bib-0039-20241115
  article-title: Nonalcoholic fatty liver disease in developing countries
  publication-title: World J Gastroenterol
  doi: 10.3748/wjg.v11.i24.3808
SSID ssj0001921190
Score 2.3657143
Snippet In order to determine the relationship between socioeconomic deprivation and nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH), we...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
wiley
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 550
SubjectTerms Aged
Alcohol
Biopsy
Body Mass Index
Child, Preschool
Cholangitis
Diabetes
Electronic health records
Fatty liver
Fibrosis
Hispanic Americans
Humans
Inflammation
Liver diseases
Metabolic syndrome
Non-alcoholic Fatty Liver Disease - diagnosis
Original
Patients
Population
Retrospective Studies
Risk factors
Socioeconomic Factors
Weight control
Womens health
SummonAdditionalLinks – databaseName: Health & Medical Collection
  dbid: 7X7
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT9wwEB61IKFeUEtpCYUqVBy4BBI7iZ0Tgha0RQJxAGlvluPYgISSZTcc-PfMeL0LK2hveYwiZzye-fyYbwB2jZRcU9qHtnWTIP7niS6tS0qeZcJhDCw9A9_5RTm4zs-GxTAsuE3CscqZT_SOuukMrZEfEK84o2_Jw9FDQlWjaHc1lND4CMsZIhEq3SCG4mWNpSL-snRGKJSyg1s7yvfRirOFMOTZ-t-DmG9PSr5GsD4EnX6G1YAd46NpZ3-BD7Zdg5XzsDv-Ff6GbI_-KfZ5KDYkHcd_7GgcqpjFl2OS7yfxBWFwXx8XJehYb99hu8l67ibrcH16cvV7kIRSCYkpMLwkTBeFwdhtU5MxZzGq60rnHB2xRoCHt5ynUktbYXhvcAbHGuG4IFJaUYoar7_BUtu1dgNiy3KHIM6apkhzp7l2qLhaFogshasli2BvpjllAo84lbO4V1MGZKZIyYqUHMGvuehoSp7xntAxqX8uQHzX_kE3vlFh-ChtJcNWalbUPHemqjR3CDVLk9IMVcsItmadp8IgnKgXk4lgZ_4ahw_tiejWdo8ogwAMnRKC1gi-T_t63hKel6VEhBaBWLCChaYuvmnvbj1FN7puiv-oK28v__57NTi5zOli8_9_8AM-MUq88KfftmCpHz_abYRDff3T2_wzdHEJBQ
  priority: 102
  providerName: ProQuest
– databaseName: Wiley Online Library Open Access
  dbid: 24P
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV1La-MwEB5CC0svZbvbh7fZxVt66MWtI8m2TE_7SMgWUnLYQm5CdqSmUJyQuIf--87IirOhLezNtsYgj-bxSdZ8AjgvpeSayj60KaYR4n8e6dTYKOW9XmYxB6aOgW90mw7vxM0kmXTgel0L0_BDtAtu5BkuXpOD62J1tSENnZmFuESDxKnPLoJ6TubNxHizwJITeRmtsTAMwBFOhCZrZqGYXbVvb-UjR9v_FtZ8vWXyXyjrctHgI-x7EBn-aEb9ADqm-gQfRv43-Wf448s-6ufQFaQYX30c_jaLpT_OLBwvSb5ehbcExt1BuShB-3vrOfabzOhhdQh3g_7fX8PIn5kQlYn7TJ0kJSZxE5c9Zg2md51rwTEia0R6eMt5LLU0Oeb5KU7l2DSzPCN22izNCrw-gp1qXpkTCA0TFtGcKadJLKzm2qLiCpkgxMxsIVkAF2vNqdITitO5Fo-qoUJmipSsSMkBnLWii4ZF4y2hn6T-VoCIr92D-fJeeT9S2kiGvdQsKbiwZZ5rbhFzpmVMU1UtA-iuB095b1wp4qRnZIfY_L1tRj-inyO6MvMnlEEkhtEJ0WsAx81Ytz3hIk0lQrUAsi0r2Orqdkv1MHNc3RjDCQigrpy9vP_1atgfC7r48v-ip7DHqBrDbYnrwk69fDJfESPVxTfnCy9nZgsJ
  priority: 102
  providerName: Wiley-Blackwell
Title Community Socioeconomic Deprivation Predicts Nonalcoholic Steatohepatitis
URI https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fhep4.1831
https://www.ncbi.nlm.nih.gov/pubmed/34668658
https://www.proquest.com/docview/2632244838
https://www.proquest.com/docview/2584017575
https://pubmed.ncbi.nlm.nih.gov/PMC8870017
https://doaj.org/article/ae827f3a25b34fc99a3f4056c01840a8
Volume 6
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9swDCa2DBh2KbZ1D7dd4BY79OLVlmTLPqZbiqxAg2BohmAXQXYkpEPhBIl76L8vKStBgnXopRe_xINMUuInSPwI8LXKc64p7UObchoh_ueRzoyNMp4k0mIMzBwD39UwG4zF5SSdbJX6ojNhLT1wq7gzbXImLdcsLbmwVVFobhFkZFVMaxPt0nzjIt5aTP1tcUuCoW5NJRSzs5lZiG_ov8lOAHI8_Y-By3_PSG5jVxd8Lt7CnkeNYa_t7Tt4Yer38PrK74vvw0-f59Hchy4Dxfh04_CHWSx9_bJwtCT5ZhUOCX27yrgoQQd6mzn2m_zmZvUBxhf96--DyBdJiKoUA0vEdJpWGLVNXCXMGoznutCC4xSsEdrhK-dxrnNTYGCf4tqNTVGbkuhoZSZLfP4InXpem88QGiYswjdTTdNYWM21RcWVeYqYUtoyZwGcrjWnKs8gToUsblXLfcwUKVmRkgM42YguWtqMx4TOSf0bAWK6dh_Q_srbXz1l_wCO1sZTfvitFJHQM3I8bD7eNOPAod0QXZv5Hcog9MLpCOFqAJ9aW296wkWW5YjNApA7XrDT1d2W-mbmyLlx0qbIj7py_vL_v1eD_kjQw8FzqOEQ3jBKzHCn446g0yzvzBeES03ZhZdMjPAqJ7ILr3q_x3_GeD_vD0e_um7UPAAXIRZR
linkProvider Directory of Open Access Journals
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3db9MwED-NTgJeEN8EBgQEEi9hqZ0P52FCjHVq2VpVaJP2ZhzHZpNQUtpMaP8cfxt3rtNRMXjbWz5OkXO2735n-34H8EYLwRWlfShTVhHifx6pzNgo4_1-btEHZo6BbzzJhsfJ55P0ZAN-dbkwdKyys4nOUFeNpjXybeIVZ_Qt8WH2I6KqUbS72pXQUL60QrXjKMZ8YseBufiJIdxiZ7SH_f2Wsf3B0adh5KsMRDpFyxwxlaYa3Z6JdZ9Zgw5RFSrhaMMUYiO8xYhfKGEK9IwVBj-syi3Pic81z_ISr_G7N2AzoQWUHmzuDibTL5erPAUxqMUdpVHMtk_NLHmP86i_5ghdvYCrQO7fZzX_xNDOCe7fhTsevYYfl8PtHmyY-j7cHPv9-Qcw8vkm7UXoMmGMT3sO98xs7uuohdM5ybeLcEJRgKvQixJ0sLhtsN00fs8WD-H4WtT4CHp1U5snEBqWWISRRldpnFjFlUXFlSJFbJvbUrAA3nWak9ozmVNBje9yycHMJClZkpIDeL0SnS3pO64S2iX1rwSIcds9aObfpJ_AUhnBsJWKpSVPrC4KxS2C3UzHFCMrEcBW13nSm4GFvBy0AbxavcYJTLsyqjbNOcogBESziLA5gMfLvl61hCdZJhAjBpCvjYK1pq6_qc9OHUk4Og9CIKgrN17-_fdyOJgmdPH0_3_wEm4Nj8aH8nA0OXgGtxmlgbizeFvQa-fn5jmCs7Z84WdACF-ve9L9BjDzSYE
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3fb9MwED6NIU28IH4TGBAQSLyEprYTJw8IAV3VMlb1gUl9M05is0koKW0mtH-Nv447x-moGLztLW1OkXM-332O774DeFlmGddU9qFNUUWI_3mkU2OjlA-H0mIMTB0D39EsnRyLT4tksQO_-loYSqvsfaJz1FVT0jfyAfGKM3pWNrA-LWI-Gr9b_oiogxSdtPbtNDoTOTTnP3H7tn47HeFcv2JsfPDl4yTyHQaiMkGvHDGdJCWGPBOXQ2YNBkOda8HRf2nERfgTd_uZzkyOUbHCjQ-rpOWSuFxlKgu8xudeg-uSC0FtI-RCXnzfyYk7Le7JjGI2ODFL8QZX0HArBLpOAZfB27-zNP9Ezy78jW_BTY9bw_edod2GHVPfgb0jfzJ_F6a-0qQ9D10NjPEFz-HILFe-g1o4X5F8uw5nhP9db16UoJTitsFxk-Weru_B8ZUo8T7s1k1tHkJomLAIIE1ZJbGwmmuLiiuyBFGttEXGAnjda06VnsOcWml8Vx37MlOkZEVKDuDFRnTZEXdcJvSB1L8RIK5t90ez-qb80lXaZAxHqVlScGHLPNfcIsxNy5h2xzoLYL-fPOUdwFpdmGsAzze3cenSeYyuTXOGMgj-0CEiYA7gQTfXm5FwkaYZosMA5JYVbA11-059euLowTFsEPZAXTl7-ffbq8nBXNDFo_-_wTPYw6WmPk9nh4_hBqP6D5eEtw-77erMPEFU1hZPnfmH8PWq19tvKABHHQ
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Community+Socioeconomic+Deprivation+Predicts+Nonalcoholic+Steatohepatitis&rft.jtitle=Hepatology+communications&rft.au=Alexa+M.+Giammarino&rft.au=He+Qiu&rft.au=Kishen+Bulsara&rft.au=Sabrina+Khan&rft.date=2022-03-01&rft.pub=Wolters+Kluwer+Health%2FLWW&rft.eissn=2471-254X&rft.volume=6&rft.issue=3&rft.spage=550&rft.epage=560&rft_id=info:doi/10.1002%2Fhep4.1831&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_ae827f3a25b34fc99a3f4056c01840a8
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2471-254X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2471-254X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2471-254X&client=summon